Phillip G. Febbo
Chief Scientific & Med Officer at Veracyte, Inc. (VCYT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 4SEC | VCYTVeracyte, Inc. | Sell Plan | 10,405135,753 held (−7%) | $42.89 | $446K | +0.5% |
| Sep 4SEC | VCYTVeracyte, Inc. | Sell Plan | 2,705133,048 held (−2%) | $43.66 | $118K | -1.2% |
| Mar 4SEC | VCYTVeracyte, Inc. | Sell Plan | 13,425117,346 held (−10%) | $36.16 | $485K | +19.2% |
| Oct 7SEC | VCYTVeracyte, Inc. | Sell Plan | 8,34992,441 held (−8%) | $36.02 | $301K | +19.7% |
- Sell
Chief Scientific & Med Officer Phillip G. Febbo sold $446K of VCYT at $42.89 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific & Med Officer Phillip G. Febbo sold $118K of VCYT at $43.66 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific & Med Officer Phillip G. Febbo sold $485K of VCYT at $36.16 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific & Med Officer Phillip G. Febbo sold $301K of VCYT at $36.02 — pre-scheduled 10b5-1 plan sale.